UNH

SEC source: 0000731766-10-000059 · edgardoc.xml · nonDerivative · entry 1

Shine Kenneth Irwin · CIK 0001455025 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,564

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board.

SEC source: 0000731766-10-000042 · edgardoc.xml · derivative · entry 3

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2010-04-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-10-000042 · edgardoc.xml · nonDerivative · entry 1

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,551,873

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-10-000043 · edgardoc.xml · derivative · entry 3

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2010-10-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-10-000043 · edgardoc.xml · nonDerivative · entry 2

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,793

SEC source: 0000731766-10-000043 · edgardoc.xml · nonDerivative · entry 1

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,793

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-10-000040 · edgardoc.xml · nonDerivative · entry 1

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,903

F1 · price: This transaction was executed in multiple trades ranging from $33.00 to $33.091 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0000731766-10-000039 · edgardoc.xml · derivative · entry 3

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2010-04-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-10-000039 · edgardoc.xml · nonDerivative · entry 2

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,903

F1 · price: This transaction was executed in multiple trades ranging from $33.29 to $33.2915 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0000731766-10-000039 · edgardoc.xml · nonDerivative · entry 1

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,903

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-10-000038 · edgardoc.xml · nonDerivative · entry 1

RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,758

F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000036 · edgardoc.xml · derivative · entry 7

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2010-10-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-10-000036 · edgardoc.xml · derivative · entry 6

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2010-07-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-10-000036 · edgardoc.xml · nonDerivative · entry 2

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 912,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-10-000036 · edgardoc.xml · nonDerivative · entry 1

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 902,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-10-000025 · edgardoc.xml · derivative · entry 5

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,200,000 shares

Expires 2010-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-10-000025 · edgardoc.xml · nonDerivative · entry 3

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,651,850

F3 · shares: Represents a "net exercise" of an aggregate of 1,200,000 stock options where 835,077 shares were used to pay the exercise price and taxes, and the remaining net 364,923 shares were issued to and retained by Mr. Hemsley.

SEC source: 0000731766-10-000025 · edgardoc.xml · nonDerivative · entry 2

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,486,927

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000731766-10-000024 · edgardoc.xml · derivative · entry 2

BOUDREAUX GAIL · CIK 0001287920 · EVP & Pres, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,024

Underlying: Common Stock · 76,024 shares

Expires 2020-02-09

F3 · derivative.exercise_date: The stock appreciation rights will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

SEC source: 0000731766-10-000024 · edgardoc.xml · nonDerivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · EVP & Pres, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,575

F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2010, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 60,607. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000025 · edgardoc.xml · derivative · entry 6

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,036

Underlying: Common Stock · 114,036 shares

Expires 2020-02-09

F4 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

SEC source: 0000731766-10-000025 · edgardoc.xml · nonDerivative · entry 1

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,286,927

F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2010, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 90,910. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000026 · edgardoc.xml · derivative · entry 3

Mikan George Lawrence III · CIK 0001381037 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,024

Underlying: Common Stock · 76,024 shares

Expires 2020-02-09

F3 · derivative.exercise_date: The stock appreciation rights will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

SEC source: 0000731766-10-000026 · edgardoc.xml · nonDerivative · entry 1

Mikan George Lawrence III · CIK 0001381037 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,623

F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2010, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 60,607. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000027 · edgardoc.xml · derivative · entry 3

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,024

Underlying: Common Stock · 76,024 shares

Expires 2020-02-09

F3 · derivative.exercise_date: The stock appreciation rights will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

SEC source: 0000731766-10-000027 · edgardoc.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,783

F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2010, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 60,607. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000028 · edgardoc.xml · derivative · entry 4

RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,006

Underlying: Common Stock · 19,006 shares

Expires 2020-02-09

F3 · derivative.exercise_date: The stock appreciation rights will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

SEC source: 0000731766-10-000028 · edgardoc.xml · nonDerivative · entry 1

RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,619

F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2010, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 15,152. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000029 · edgardoc.xml · derivative · entry 2

RENFRO LARRY C · CIK 0001235046 · EVP & CEO Publc & Sr Mkts Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,024

Underlying: Common Stock · 76,024 shares

Expires 2020-02-09

F3 · derivative.exercise_date: The stock appreciation rights will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

SEC source: 0000731766-10-000029 · edgardoc.xml · nonDerivative · entry 1

RENFRO LARRY C · CIK 0001235046 · EVP & CEO Publc & Sr Mkts Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,124

F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2010, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 60,607. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000030 · edgardoc.xml · derivative · entry 3

Sweere Lori · CIK 0001407932 · EVP, Human Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,012

Underlying: Common Stock · 38,012 shares

Expires 2020-02-09

F3 · derivative.exercise_date: The stock appreciation rights will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

SEC source: 0000731766-10-000030 · edgardoc.xml · nonDerivative · entry 1

Sweere Lori · CIK 0001407932 · EVP, Human Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,509

F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2010, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 30,304. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000031 · edgardoc.xml · derivative · entry 2

Walsh Christopher James · CIK 0001475141 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,012

Underlying: Common Stock · 38,012 shares

Expires 2020-02-09

F3 · derivative.exercise_date: The stock appreciation rights will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

SEC source: 0000731766-10-000031 · edgardoc.xml · nonDerivative · entry 1

Walsh Christopher James · CIK 0001475141 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,581

F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2010, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 30,304. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000032 · edgardoc.xml · derivative · entry 3

WICHMANN DAVID S · CIK 0001268489 · EVP & Pres, UHG Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,024

Underlying: Common Stock · 76,024 shares

Expires 2020-02-09

F3 · derivative.exercise_date: The stock appreciation rights will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

SEC source: 0000731766-10-000032 · edgardoc.xml · nonDerivative · entry 1

WICHMANN DAVID S · CIK 0001268489 · EVP & Pres, UHG Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,331

F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2010, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 60,607. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000033 · edgardoc.xml · derivative · entry 2

Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,012

Underlying: Common Stock · 38,012 shares

Expires 2020-02-09

F3 · derivative.exercise_date: The stock appreciation rights will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

SEC source: 0000731766-10-000033 · edgardoc.xml · nonDerivative · entry 1

Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,216

F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2010, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 30,304. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000034 · edgardoc.xml · derivative · entry 2

WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,024

Underlying: Common Stock · 76,024 shares

Expires 2020-02-09

F3 · derivative.exercise_date: The stock appreciation rights will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

SEC source: 0000731766-10-000034 · edgardoc.xml · nonDerivative · entry 1

WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,613

F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2010, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 60,607. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000012 · edgardoc.xml · nonDerivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · EVP & Pres, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,271

F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000013 · edgardoc.xml · nonDerivative · entry 1

Mikan George Lawrence III · CIK 0001381037 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,319

F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000014 · edgardoc.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,479

F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000015 · edgardoc.xml · nonDerivative · entry 1

RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,043

F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000016 · edgardoc.xml · nonDerivative · entry 1

RENFRO LARRY C · CIK 0001235046 · EVP & Pres Publc & Sr Mkts Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,820

SEC source: 0000731766-10-000017 · edgardoc.xml · nonDerivative · entry 1

Sweere Lori · CIK 0001407932 · EVP, Human Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,357

F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000018 · edgardoc.xml · nonDerivative · entry 1

Walsh Christopher James · CIK 0001475141 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,429

F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000019 · edgardoc.xml · nonDerivative · entry 1

WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,309

F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000020 · edgardoc.xml · nonDerivative · entry 1

WICHMANN DAVID S · CIK 0001268489 · EVP & Pres, UHG Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,027

F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000021 · edgardoc.xml · nonDerivative · entry 1

Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,064

F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.